Peter Traber und Nash - Info zur Person

(1 - 12 von 15

)

Peter Traber, MD on High Morbidity Rates Expected from ...cdhub360.com

www.cdhub360.com

Peter Traber, MD, discusses nonalcoholic steatohepatitis (NASH), which can progress over many years into cirrhosis and can potentially lead to the need for ... Peter Traber, MD, discusses nonalcoholic steatohepatitis (NASH), which can progress over many years into cirrhosis and can potentially lead to the need for ...

Peter Traber - Is Gilead's Selonsertib for NASH Dead?linkedin.com

www.linkedin.com

Peter Traber's Post. View profile for Peter Traber. Peter Traber. Chief Medical Officer at Selecta Biosciences. 4y. Report this post; Close menu.

Agencies Clarify NASH Endpoints--But Don't Harmonize - LinkedIn

www.linkedin.com

Peter Traber. Biotech/Pharma Consultant Partner at Alacrita. Follow. 1 comment. article-comment__guest-image. Sign in to leave your ...

Dr. Peter Traber - working on a cure for NASH, a growing epidemic ...

www.linkedin.com

Dr. Peter Traber - working on a cure for NASH, a growing epidemic due in part to the increase in obesity. Published on June 8, June 8, • 6 Likes •

Animal model of NASH Advances Field - LinkedIn

www.linkedin.com

Peter Traber. Biotech/Pharma Consultant Partner at Alacrita. Follow. 0 comments. article-comment__guest-image. Sign in to leave your ...

NASH Bubble? - LinkedIn

www.linkedin.com

Peter Traber. Biotech/Pharma Consultant Partner at Alacrita. Follow. 1 comment. article-comment__guest-image. Sign in to leave your ...

Peter Traber, MD on High Morbidity Rates Expected from ...Consultant360

www.consultant360.com

Peter Traber, MD, discusses nonalcoholic steatohepatitis (NASH), which can progress over many years into cirrhosis and can potentially lead to the need for ...

Peter Traber, MD on High Morbidity Rates Expected from NASH in ...

www.consultant360.com

› ...

Peter G. TraberSurfing the NASH Tsunami Podcast

surfingnash.com

Dr Peter Traber is a gastroenterologist/hepatologist physician executive with a distinguished career of over 30 years in drug development, life sciences.

Ep. 3 C-SUITE COVID-19 CHALLENGES - Surfing the NASH Tsunami Podcast...

surfingnash.com

Critical considerations for companies developing NASH drugs. Peter Traber focuses on ways COVID-19 can affect drug development and broader corporate strategies…

EASL The NASH PodcastSurfing the NASH Tsunami Podcast

surfingnash.com

Peter Traber, MD — Session Optimal endpoints in NAFLD clinical Trials: Histology or non-invasive biomarkers and imaging? Louise Campbell MSc AP — Session ...

Galectin PhIIb NASH trial fails the primary goal, but ...

endpts.com

Researchers in the study also also talked up positive results for a secondary endpoint on liver cell death. Galectin, led by Peter Traber, started the day with ... › galectin-phiib-...

Alle Infos zum Namen "Peter Traber"

Verwandte Suchanfragen zu Peter Traber

Daniel Traber
Ronny Traber
Alexander Traber

Pascal Traber
Markus Traber
Alfred Traber

Kevin Traber

Person "Traber" (2)
Vorname "Peter" (123603)
Name "Traber" (446)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Peter Traber und Nash Person-Info